Technology, makes health simpler
Mature platform technology Customized product services
End-to-end independent manufacturing
Technology, makes health simpler
Mature platform technology Customized product services
End-to-end independent manufacturing
-
Statement
To safeguard the brand image of ENJOSIM Medical and protect the legitimate rights and interests of consumers and partners, Shanghai Enjosim Medical Technology Co., Ltd. and its wholly-owned subsidiary, Jiangsu Enjosim Medical Technology Co., Ltd., hereby issue this solemn statement:
넶288 2025-09-07 -
英捷铸精品,信诚谱华章|英捷信医疗高精度给药装置产业化基地(一期)奠基仪式圆满举行
金秋启新程,实干筑华章。11月19日上午,江苏英捷信医疗高精度给药装置产业化基地(一期)奠基仪式于无锡锡东新城(度假区)隆重举行。
넶8 2026-11-20 -
ABOUT US
ENJOSIM MEDICAL specializes in the research, development, and manufacturing of high-precision drug delivery devices. Its product portfolio includes delivery systems for biologics such as insulin, GLP-1, and growth hormone, with an annual production capacity of nearly 100 million injection pens. The company operates a 16,000m² modern facility equipped with three fully automated MIKRON assembly lines, featuring Class 100,000 GMP-compliant cleanrooms, precision injection molding workshops, and an in-house mold manufacturing center, This supports a vertically integrated production system that covers product design, mold development, precision molding, and automated assembly. The company has secured six domestic medical device registration certificates, and achieved ISO 13485:2016 and MDSAP certifications.Its products hold EU CE certification, Canada MDL, India CDSCO registration, Brazil ANVISA registration, and an FDA DMF number. Based on the outstanding R&D capabilities, extensive experience in combination product registration, and strict medical device quality management system, the company has completed multiple rounds of strategic financing and established in-depth partnerships with numerous global biopharmaceutical leaders.The company is committed to providing high-quality drug delivery devices to the global biopharmaceutical industry through continuous innovation, promoting the development of precision medicine.
Production capacity
Injection pen model
Mikron automation assembly line
Core patents
SimTouch Pen
Matching Biologic Agents
Semaglutide,Tirzepatide,Liraglutide,Insulin,HGH,FSH etc
Disposable Prefilled Injection Pen
Matching Biologic Agents
Semaglutide,Tirzepatide,Liraglutide,Insulin,HGH,FSH etc
Two-step Auto Injector
Matching Biologic Agents
Semaglutide, Tirzepatide, Auto - Immune Biological Agents etc
Address :
Room 505, No.1B Building,No.800 Qingdai Road, Pudong New Area, Shanghai,China
Email:
sales@jsenjosim.com
-
ꁸ Top
-
ꂅ 88888888
-
ꀥ QR code
